Stähler Acquires Global Beflubutamide Rights
21 September 2007 The family-owned agrochemical producer with its headquarters in north Germany has now purchased the global development and marketing rights for beflubutamide from the Japanese company, Ube Industries Ltd. Included in the transaction was the the complete data package for the Annex I listing of the a.i.
Beflubutamide is a carotenoid biosynthesis inhibitor with good efficacy against a wide spectrum of broadleaf weeds. It also demonstrates control against widely distributed grass weeds, such as Apera, and strong selectivity, which accounts for excellent crop tolerance. Beflubutamide can be applied to cereals both in autumn and spring and can be integrated into virtually all cultivation regimes, according to Stähler.
Currently in Europe, beflubutamide is marketed in combination with isoproturon under the trade name HERBAFLEX in addition Germany, Austria, Belgium, Bulgaria, Croatia, Czech Republic, Hungary, Luxemburg, Slovakia, and Slovenia.
Stähler is expecting further registrations of thie a.i., including other combinations of beflubutamide in all significant European markets. The company plans to achieve an annual turnover of at least 10 million Euros within five years with this product line, primarily in wheat.
Dr. Henning Goetzke, Leitung Marketing for Stähler, told FCI that “the general focus of the Stähler group are the European markets,” and that “the existing beflubutamide product Herbaflex, however, is not only registered in wheat, but also in barley, rye, and triticale.”
Get The Newsletter Today!
